Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases

NCT06888817 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

408

Enrollment

OTHER

Sponsor class

Conditions

Radiation Necrosis
High Grade Glioma (III or IV)
Brain Metastasases
Radiation Toxicity
Radiation Effect
Radiation Injury
Radiation Injuries

Interventions

DRUG: Bevacizumab
DRUG: Dexamethasone

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]